TITLE:
Durational Therapeutic Dose of Fansidar: A Functional Index in Its Antidiabetic Properties
AUTHORS:
E. O. Jimmy
KEYWORDS:
Durational Dosage, Diabetes, Antidiabetic Potentials
JOURNAL NAME:
Journal of Biosciences and Medicines,
Vol.7 No.1,
January
4,
2019
ABSTRACT: Effects of fansidar in
alloxan-induced diabetes were investigated in thirty (30) male and female albino rats for 28 days. The
results showed a steady weekly decrease in blood glucose concentration in
induced diabetic rats after fansidar treatment. In week 1, i.e. 7 days, there was significant difference in the blood glucose
levels between the control and diabetic rats (P i.e. high glucose concentration, same in week II i.e. 14 days. However, in day 21 i.e. week
III there was a significant reduction in the blood glucose concentration
compared with control P i.e. in 28 days treatment. The result
has shown that fansidar has antidiabetic potentials on long term durational
administration.